The plasma glutamate concentration as a complementary tool to differentiate benign PET-positive lung lesions from lung cancer
Abstract Background Pulmonary imaging often identifies suspicious abnormalities resulting in supplementary diagnostic procedures. This study aims to investigate whether the metabolic fingerprint of plasma allows to discriminate between patients with lung inflammation and patients with lung cancer. M...
Main Authors: | K. Vanhove, P. Giesen, O. E. Owokotomo, L. Mesotten, E. Louis, Z. Shkedy, M. Thomeer, P. Adriaensens |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-09-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4755-1 |
Similar Items
-
The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism
by: Karolien Vanhove, et al.
Published: (2019-11-01) -
Detection of Lung Cancer via Blood Plasma and <sup>1</sup>H-NMR Metabolomics: Validation by a Semi-Targeted and Quantitative Approach Using a Protein-Binding Competitor
by: Elien Derveaux, et al.
Published: (2021-08-01) -
Glutamine Addiction and Therapeutic Strategies in Lung Cancer
by: Karolien Vanhove, et al.
Published: (2019-01-01) -
Blood Glutamate Levels Are Closely Related to Acute Lung Injury and Prognosis after Stroke
by: Wei Bai, et al.
Published: (2018-01-01) -
A Retrospective Study of Mean Computed Tomography Value to Predict
the Tumor Invasiveness in AAH and Clinical Stage Ia Lung Cancer
by: Hanran WU, et al.
Published: (2018-03-01)